Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3010% above fair value
$259.60−0.05 (-0.02%)
Close on Nov 13, 2026Market cap $28.56BP/E 25.9Yield –
Quest Diagnostics statistics
103 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 9, 2027 (estimated, before the open)
- Last ex-dividend date
- Oct 6, 2026
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 14.64
- 14.68
Enterprise valuationIndustry
- EV / Sales
- 2.84
- 1.67
- EV / EBIT
- 19.52
- 20.51
- EV / FCF
- 24.46
- 24.49
Share statisticsIndustry
- Shares Change (YoY)
- -1.32%
- 2.40%
- Float
- 109M
- 34M
- Shares Held by Insiders
- 0.48%
- 15.4%
- Shares Held by Institutions
- 95.4%
- 83.6%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 4.48%
- -0.86%
- Short % of Float
- 3.41%
- 6.28%
- Short % of Shares Outstanding
- 3.39%
- 4.21%
- Days to Cover
- 3.64
- 4.41
Stock price statisticsIndustry
- 52-Week High
- $262.00
- –
- 52-Week Low
- $171.18
- –
- 20-Day Moving Average
- $249.60
- –
- 50-Day Moving Average
- $241.30
- –
- 200-Day Moving Average
- $215.70
- –
- Average True Range (14)
- $5.85
- –
- Price Change (1 Week)
- 1.55%
- 0.23%
- Price Change (1 Month)
- 8.55%
- -0.02%
- Price Change (3 Months)
- 10.2%
- 2.13%
- Price Change (6 Months)
- 39.1%
- 17.6%
- Price Change (YTD)
- 49.6%
- 5.22%
- Price Change (1 Year)
- 38.9%
- 3.75%
- Price Change (3 Years)
- 94.0%
- 15.2%
- Price Change (5 Years)
- 73.1%
- -14.6%
- Price Change (10 Years)
- 205.1%
- 184.8%
- Average Volume (10 Days)
- 889,384
- –
- Average Volume (20 Days)
- 968,228
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.64
- 0.70
- Relative Strength Index (14)
- 69.1
- 46.0
- Volatility (1 Year)
- 23.9%
- 64.2%
- Beta (5 Years)
- 0.32
- 0.76
MarginsIndustry
- Pretax Margin
- 12.6%
- 2.12%
- EBITDA Margin
- 19.5%
- 3.36%
- FCF Margin
- 11.6%
- 2.98%
Returns on capitalIndustry
- Return on Equity (ROE)
- 15.2%
- 4.82%
- Return on Assets (ROA)
- 6.76%
- -3.10%
- Return on Invested Capital (ROIC)
- 10.7%
- 4.69%
- Return on Capital Employed (ROCE)
- 11.2%
- 0.40%
Financial positionIndustry
- Current Ratio
- 1.70
- 1.41
- Quick Ratio
- 1.37
- 0.99
- Debt / Equity
- 0.73
- 0.68
- Debt / EBITDA
- 2.40
- 2.50
- Debt / FCF
- 4.04
- 4.01
- Net Debt / EBITDA
- 2.06
- 2.13
GrowthIndustry
- Revenue Growth (YoY)
- 9.13%
- 9.63%
- Net Income Growth (YoY)
- 16.5%
- 16.5%
- EPS Growth (YoY)
- 18.3%
- 19.0%
- FCF Growth (YoY)
- -1.29%
- -6.64%
- Revenue Growth (3Y CAGR)
- 3.74%
- 11.3%
- Revenue Growth (5Y CAGR)
- 3.18%
- 12.6%
- EPS Growth (3Y CAGR)
- 3.16%
- 19.8%
- EPS Growth (5Y CAGR)
- -3.53%
- 9.29%
EfficiencyIndustry
- Asset Turnover
- 0.71
- 0.81
- Inventory Turnover
- 39.21
- 10.99
- Revenue Per Employee
- $207.74K
- $235.26K
- Profits Per Employee
- $19.81K
- -$5.12K
- Employee Count
- 57,000
- 910
- WACC
- 7.25%
- 8.40%
Income statement (TTM)Industry
- Pretax Income
- $1.49B
- -$575.82K
Balance sheetIndustry
- Net Cash (Debt)
- -$4.75B
- $203.66K
- Net Cash Per Share
- -$43.20
- $0.00
- Equity (Book Value)
- $7.63B
- $235.60M
- Book Value Per Share
- $69.37
- $3.91
- Tangible Book Value
- -$3.11B
- $1.59M
- Working Capital
- $1.28B
- $30.06M
Cash flow (TTM)Industry
- Capital Expenditures
- -$576.00M
- -$15.83M
- FCF Per Share
- $12.50
- $0.36
Dividends and yieldsIndustry
- Earnings Yield
- 3.95%
- 0.19%
- FCF Yield
- 4.81%
- 2.55%
- Payout Ratio
- 32.7%
- 13.4%
- FCF Payout Ratio
- 26.8%
- 11.9%
Taxes and interestIndustry
- Income Tax
- $342.00M
- $564.50K
- Effective Tax Rate
- 22.9%
- 24.1%
Scores and fair valueIndustry
- Graham Number
- $125.12
- $21.25
- Graham Upside
- -51.8%
- -49.9%
- Altman Z-Score
- 3.82
- 2.24
- Piotroski F-Score
- 7
- 5
- Beneish M-Score
- -2.65
- -2.76
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | DGX | S&P 500 | Difference | DGX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +12.6% | -3.0% | +15.7 pts | ||
| 3 months | +10.4% | -2.8% | +13.2 pts | ||
| Year to date | +52.1% | +11.5% | +40.6 pts | ||
| 1 year | +40.7% | +13.5% | +27.3 pts | ||
| 3 years | +107.6% | +77.7% | +29.9 pts | +27.6% | +21.1% |
| 5 years | +90.6% | +72.6% | +18.0 pts | +13.8% | +11.5% |
| 10 years | +287.9% | +308.2% | −20.2 pts | +14.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M DGX shares were sold short on Oct 30, 2026, up 4.5% from the previous report, or 3.41% of the shares available to trade. At recent volumes it would take 3.6 days to buy them back. Over the last 20 sessions, 66.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,734,103 | +4.5% | 1,024,579 | 3.6 |
| Oct 15, 2026 | 3,573,902 | +4.6% | 1,055,988 | 3.4 |
| Sep 30, 2026 | 3,417,577 | -5.1% | 1,268,667 | 2.7 |
| Sep 15, 2026 | 3,600,559 | +4.5% | 975,562 | 3.7 |
| Aug 31, 2026 | 3,445,561 | +3.7% | 893,699 | 3.9 |
| Aug 14, 2026 | 3,321,414 | -9.8% | 711,512 | 4.7 |
| Jul 31, 2026 | 3,684,192 | +5.0% | 1,344,732 | 2.7 |
| Jul 15, 2026 | 3,509,407 | -6.0% | 823,847 | 4.3 |
| Jun 30, 2026 | 3,732,507 | +9.1% | 971,160 | 3.8 |
| Jun 15, 2026 | 3,419,621 | -0.3% | 802,904 | 4.3 |
| May 29, 2026 | 3,430,849 | -7.6% | 822,173 | 4.2 |
| May 15, 2026 | 3,715,019 | +9.6% | 744,798 | 5.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?